Literature DB >> 11331417

Caspase-2 activation is redundant during seizure-induced neuronal death.

D C Henshall1, S L Skradski, D P Bonislawski, J Q Lan, R P Simon.   

Abstract

Seizure-induced neuronal death may be under the control of the caspase family of cell death proteases. We examined the role of caspase-2 in a model of focally evoked limbic seizures with continuous EEG recording. Seizures were elicited by microinjection of kainic acid into the amygdala of the rat and terminated after 40 min by diazepam. Caspase-2 was constitutively present in brain, mostly within neurons, and was detected in both cytoplasm and nucleus. Cleaved caspase-2 (12 kDa) was detected immediately following seizure termination within injured ipsilateral hippocampus, contiguous with increased Val-Asp-Val-Ala-Asp (VDVADase) activity, a putative measure of activated caspase-2. Expression of receptor interacting protein (RIP)-associated Ich-1-homologous protein with death domain (RAIDD) was increased following seizures, whereas expression of RIP and tumor necrosis factor receptor associated protein with death domain (TRADD), other components thought to be linked to the caspase-2 activation and signaling mechanism, were unchanged. Intracerebroventricular administration of z-VDVAD-fluoromethyl ketone blocked seizure-induced caspase-2 activity but did not alter caspase-8 activity and failed to affect DNA fragmentation or neuronal death. These data support activation of caspase-2 following seizures but suggest that parallel caspase pathways may circumvent deficits in caspase-2 function to complete the cell death process.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11331417     DOI: 10.1046/j.1471-4159.2001.00291.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  9 in total

1.  Apoptosis, Bcl-2 family proteins and caspases: the ABCs of seizure-damage and epileptogenesis?

Authors:  Tobias Engel; David C Henshall
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2009-03-30

2.  Effects of piperine and deoxyschizandrin on synchronized Ca²⁺ oscillations in cultured hippocampal neuronal cells.

Authors:  Shu Zhang; Xiaochen Liu; Wanyun Ma
Journal:  Eur Biophys J       Date:  2013-06-15       Impact factor: 1.733

3.  Activation of the caspase 8 pathway mediates seizure-induced cell death in cultured hippocampal neurons.

Authors:  R Meller; C Clayton; D J Torrey; C K Schindler; J Q Lan; J A Cameron; X P Chu; Z G Xiong; R P Simon; D C Henshall
Journal:  Epilepsy Res       Date:  2006-03-20       Impact factor: 3.045

4.  The PIDDosome mediates delayed death of hippocampal CA1 neurons after transient global cerebral ischemia in rats.

Authors:  Kuniyasu Niizuma; Hidenori Endo; Chikako Nito; D Jeannie Myer; Gab Seok Kim; Pak H Chan
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-09       Impact factor: 11.205

5.  Apoptosis through Death Receptors in Temporal Lobe Epilepsy-Associated Hippocampal Sclerosis.

Authors:  Marcelo Ananias Teocchi; Lília D'Souza-Li
Journal:  Mediators Inflamm       Date:  2016-02-23       Impact factor: 4.711

Review 6.  The Role of Caspase-2 in Regulating Cell Fate.

Authors:  Vasanthy Vigneswara; Zubair Ahmed
Journal:  Cells       Date:  2020-05-19       Impact factor: 6.600

7.  Adenosine A1 Receptor Agonist (R-PIA) before Pilocarpine Modulates Pro- and Anti-Apoptotic Factors in an Animal Model of Epilepsy.

Authors:  Daniele Suzete Persike; Rebeca Padrão Amorim Puccinelli; Maria José da Silva Fernandes
Journal:  Pharmaceuticals (Basel)       Date:  2021-04-18

Review 8.  Modulation of apoptotic pathways by human papillomaviruses (HPV): mechanisms and implications for therapy.

Authors:  Chung-Hsiang Yuan; Maria Filippova; Penelope Duerksen-Hughes
Journal:  Viruses       Date:  2012-12-18       Impact factor: 5.048

9.  Increased expression of caspase 2 in experimental and human temporal lobe epilepsy.

Authors:  Susanna Narkilahti; Leena Jutila; Irina Alafuzoff; Kari Karkola; Leo Paljärvi; Arto Immonen; Matti Vapalahti; Esa Mervaala; Reetta Kälviäinen; Asla Pitkänen
Journal:  Neuromolecular Med       Date:  2007       Impact factor: 4.103

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.